What's Going On With Beyond Inc Stock?

Beyond, Inc. BYON shares are moving Monday, and the stock is up more than 9% over the past month. Here's a look at what to know.

What To Know:

Two analysts raised price targets on Beyond last week. Barclays maintained Beyond with an Equal-Weight and raised the price target from $20 to $24, and Needham analyst Anna Andreeva upgraded Beyond from Hold to Buy and announced a $40 price target last Friday.

The Needham report highlighted the existing Bed Bath and Beyond brand loyalty and broad market share. Needham also sees potential for the company to reduce or even eliminate some of its fixed expenses and is encouraged by Marcus Lemonis at the helm of the company.

Lemonis transitioned to the role of chairman of the company's board of directors following the resignation of Allison Abraham on Dec. 19.

Andreeva's price target of $40 represents a nearly 56% potential upside for the stock.

It should also be noted that 12.53% of available Beyond shares are being sold short, according to data from Benzinga Pro.

Related News: What's Going On With BioCryst Pharmaceuticals Stock?

BYON Price Action: According to Benzinga Pro, Beyond shares are up 1.3% at $25.67 at the time of publication.

Image: Gentelle_Linen from Pixabay